| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human Phosphoinositide 3-kinase beta P110beta/p85a |
|---|
| Description | Purity >90.0% as determined by SDS Page. Introduction: The PI3Kb isoform can be activated by insulin via the insulin receptor to initiate a cascade of events that control cell growth and metabolism. The activation ofPI3Kb is mediated by the p85 regulatory subunit binding to tyrosine phosphorylated insulin receptor substrate (IRS) proteins (e.g. IRS-1 and IRS-2). It was also shown that PI3Kb is involved in apoptosis in human colon carcinoma cells. Injection of neutralizing antibodies speci |
|---|
| Size | 0.001 mg, 0.0025 mg, 0.005 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [PI3Kb Human; Phosphoinositide 3-kinase beta p110beta/p85alpha Human Recombinant; PI3Kb] |
|---|
| Gene, Accession, CAS # | [PI3Kb] |
|---|
| Catalog # | MBS142827 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human Phosphoinositide 3-kinase beta P110beta/p85a from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|